The portfolio's three largest holdings (Amgen, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals ... who covers medical technology. In June 2024 Franklin hired a research associate, Fiona ...

The portfolio's three largest holdings (Amgen, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals ... who covers medical technology. In June 2024 Franklin hired a research associate, Fiona ...

Investors in Vertex Pharmaceuticals, Inc. (Symbol: VRTX) saw new options begin trading today, for the June 2027 expiration. One of the key inputs that goes into the price an option buyer is ...

Investors eye Vertex’s Q1 for Alyftrek and Journavx momentum amid Trikafta’s international headwinds. Vertex stock shows a bullish technical bias despite recent pullback and mixed short-term ...

As previously reported, Cantor Fitzgerald assumed coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and a price target of $535, up from $480. Vertex remains well-positioned with ...

Vertex (VERX) announced the expansion of its Chief Strategy Office with the addition of Christopher Hall and Kathya Capote Peimbert. Their extensive experience in e-invoicing, global tax ...

The summer solstice happens when the sun "reaches its highest and northernmost points in the sky," the Farmer's Almanac ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

Marriage Prediction: Married Life, Mangal dosha & Remedies.

Shares of Vertex have rallied, even amid the broader stock market sell-off. The company is diversifying beyond its dominance in cystic fibrosis treatments. Several catalysts in 2025 support a ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).